IBO Impact BioMedical Inc.

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: IBO

Price (delayed)

$6.63

Market cap

$714.85M

P/E Ratio

7.53

Dividend/share

N/A

EPS

$0.88

Enterprise value

$714.84M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 100
Relative Valuation: Rel. Valuation: 70
Relative Profitability: Rel. Profitability: 28

Impact BioMedical Inc. (NYSE American: IBO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration ...

Highlights
The company's EPS has surged by 126% YoY
Impact BioMedical's net income has surged by 106% QoQ and by 102% YoY
Impact BioMedical's quick ratio has soared by 150% YoY but it has decreased by 23% from the previous quarter
Impact BioMedical's gross margin has decreased by 13% from the previous quarter
IBO's revenue is down by 10% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.impactbiomedinc.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of IBO

IBO stock price

How has the Impact BioMedical stock price performed over time
Intraday
1,156.63%
1 week
1,231.33%
1 month
1,281.25%
1 year
903.48%
YTD
1,212.87%
QTD
1,341.3%

Financial performance

How have Impact BioMedical's revenue and profit performed over time
Revenue
$35,000
Gross profit
-$389,000
Operating income
-$5.11M
Net income
$789,000
Gross margin
-1,111.4%
Net margin
2,254.3%
The net margin has surged by 107% since the previous quarter and by 100% year-on-year
Impact BioMedical's net income has surged by 106% QoQ and by 102% YoY
Impact BioMedical's operating margin has soared by 97% YoY but it has decreased by 2.4% from the previous quarter
IBO's operating income has surged by 83% year-on-year and by 8% since the previous quarter

Price vs fundamentals

How does IBO's price correlate with its fundamentals

Growth

What is Impact BioMedical's growth rate over time

Valuation

What is Impact BioMedical stock price valuation
P/E
7.53
P/B
66.4
P/S
20,424.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20,424.14
The company's EPS has surged by 126% YoY
The equity fell by 6% QoQ
The stock's price to sales (P/S) is 67% more than its last 4 quarters average of 974.3
IBO's revenue is down by 10% since the previous quarter

Efficiency

How efficient is Impact BioMedical business performance
The return on assets has surged by 106% since the previous quarter and by 103% year-on-year
The company's return on equity has surged by 103% YoY and by 100% QoQ
The company's return on sales has surged by 99% YoY and by 89% QoQ

Dividends

What is IBO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IBO.

Financial health

How did Impact BioMedical financials performed over time
The current ratio has soared by 167% year-on-year but it is down by 27% since the previous quarter
Impact BioMedical's quick ratio has soared by 150% YoY but it has decreased by 23% from the previous quarter
The debt is 100% smaller than the equity
The debt has dropped by 100% year-on-year
The debt to equity has surged by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.